Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
01/14/2009 | EP2012811A1 Use of botulinum toxin for alleviating testicular pain |
01/14/2009 | EP2012810A2 Solid support reagents for synthesis |
01/14/2009 | EP2012809A2 Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatment |
01/14/2009 | EP2012801A2 Gemcitabine combination therapy |
01/14/2009 | EP2012791A2 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors |
01/14/2009 | EP2012751A2 Novel nanoparticles for delivery of active agents |
01/14/2009 | EP2012746A2 Subcutaneous implants containing a degradation-resistant polylactide polymer and a lh-rh analogue |
01/14/2009 | EP1874281A4 Optimizing pharmacodynamics of therapeutic agents for treating vascular tissue |
01/14/2009 | EP1786453B1 Alpha-defensins as anthrax immunotherapeutics |
01/14/2009 | EP1753776B1 Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents |
01/14/2009 | EP1730172A4 Methods and compositions for the treatment of gastrointestinal disorders |
01/14/2009 | EP1704239B1 Integrase fusion proteins and their use with integrating gene therapy |
01/14/2009 | EP1689771B1 Biologically active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (ivtntt) |
01/14/2009 | EP1653844A4 Prion-specific peptide reagents |
01/14/2009 | EP1609858B1 Method for detecting substrates or inhibitors for branched neutral amino acid transporters |
01/14/2009 | EP1572967B1 Il-1 receptor based antagonists and methods of making and using |
01/14/2009 | EP1485412B1 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy |
01/14/2009 | EP1423133B1 Treatment of muscular dystrophies and related disorders |
01/14/2009 | EP1406678B1 Drug delivery matrices to enhance wound healing |
01/14/2009 | EP1377305B1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of an-giogenesis |
01/14/2009 | EP1348428B1 Powdery preparations and process for producing the same |
01/14/2009 | EP1311241B1 Use of a porous carrier |
01/14/2009 | EP1283057B1 Cell proliferation inhibitors |
01/14/2009 | EP1278537B1 Compositions for stimulating nervous system regeneration and repair by regulating arginase i and polyamine synthesis |
01/14/2009 | EP1233948B1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
01/14/2009 | EP1223978B1 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
01/14/2009 | EP1187918B2 Tek antagonists |
01/14/2009 | EP1146913B1 Conjugates of granulocyte colony stimulating factors for targeting and imaging infection and inflammation |
01/14/2009 | EP1068332B1 Recombinant anti-tumor rnase |
01/14/2009 | EP0948614B1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
01/14/2009 | EP0948539B1 Peptides and compounds that bind to a receptor |
01/14/2009 | EP0841937B2 Use of betaglycan to reduce scarring |
01/14/2009 | EP0724594B1 Regulation of transcription factor, nf-il6/lap |
01/14/2009 | CN101346155A Use of MAPC or progeny therefrom to populate lymphohematopoietic tissues |
01/14/2009 | CN101346130A Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers |
01/14/2009 | CN101343652A Mushroom ferment crude protein with antineoplastic activity, extracting method and formulation |
01/14/2009 | CN101343651A Mushroom ferment pure protein with antineoplastic activity, extracting method and formulation |
01/14/2009 | CN101343640A Common expression CTLA4Ig and CTLA4 recombinant adenovirus carrier, recombinant adenovirus and uses thereof |
01/14/2009 | CN101343624A Recombined human growth hormone gene bacilliform virus, preparation and application thereof |
01/14/2009 | CN101343623A Hybrid tumor, antihuman bladder cancer monoantibody and guide medicament, and bladder cancer diagnosis agent |
01/14/2009 | CN101343328A Target-specificity dual-mutant amalgamation protein |
01/14/2009 | CN101343327A Antiviral protein and uses thereof |
01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
01/14/2009 | CN101343318A Peptide-polymer conjugates |
01/14/2009 | CN101343313A Glucose dipeptide compounds, preparation method and application thereof |
01/14/2009 | CN101343251A Thrombopoietin mimetics |
01/14/2009 | CN101343250A Thrombopoietin mimetics |
01/14/2009 | CN101342371A Application of LYRM1 gene in preparing medicament for promoting fat cell proliferation |
01/14/2009 | CN101342366A SOD oxidation resistant composition and preparation thereof |
01/14/2009 | CN101342365A Use of novel glucagon-like peptide-1 (GLP-1) analogue |
01/14/2009 | CN101342196A Compound spirulina |
01/14/2009 | CN101342169A Thrombopoietin mimetics |
01/14/2009 | CN100451127C Peptides with anti-hypertensive properties |
01/14/2009 | CN100451115C Modulators of intracellular inflamation, cell death and cell survival pathways containing a card and kinase domain |
01/14/2009 | CN100451114C Infuse protein of candida albicans hot shock protein 90 epitope and phage envelop protein , and its uses |
01/14/2009 | CN100451034C Pig gamma interferon and encoding genes and use thereof |
01/14/2009 | CN100451033C Gene for inhibiting human transcription factor AP-1, its encoding polypeptide and uses |
01/14/2009 | CN100451032C Oyster low molecular active peptide and its preparation method and application in the preparation of anticancer medicine |
01/14/2009 | CN100450551C Recombinated adeno-associated virus genes vaccine for prevention and cure of Alzheimer disease and use thereof |
01/14/2009 | CN100450547C Medicinal compositions for improving oral absorption |
01/14/2009 | CN100450546C Compound preparation for dissolving staphyloase and preparation method |
01/14/2009 | CN100450545C Application of musculus growth inhibin for preparing anticarcinogen |
01/14/2009 | CN100450544C Compound medicinal preparation for treating femur necrosis |
01/14/2009 | CN100450543C Animal medicine capable of increasing immunologic function of livestock and birds |
01/14/2009 | CN100450542C Formulation for a protein pharmaceutical without added human serum albumin (HSA) |
01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
01/13/2009 | US7477177 A-D converter, A-D convert method, and A-D convert program |
01/13/2009 | US7476786 Using nanoparticles to identify and/or sequence biomolecules; forensic analysis; medical diagnostics |
01/13/2009 | US7476754 Biphenyl derived thiamides as calpain inhibitors |
01/13/2009 | US7476742 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate |
01/13/2009 | US7476732 Nucleic acid encoding α chain of human IL-11 receptor |
01/13/2009 | US7476731 Variants of the alpha 1 subunit of human AMPK |
01/13/2009 | US7476729 Dbait and uses thereof |
01/13/2009 | US7476728 Flea GABA receptor subunit nucleic acid molecules |
01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
01/13/2009 | US7476720 Rat neurotrophic factor receptor, GFR α-4 |
01/13/2009 | US7476719 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
01/13/2009 | US7476669 Immobilization of taxane; anticancer, antitumor agents |
01/13/2009 | US7476657 Appear to function at least in part by inhibiting G2 cell cycle checkpoint; useful in treating metastatic and non-metastatic solid or liquid tumors |
01/13/2009 | US7476656 Cysteamine moiety covalently attached to a phthalein, xanthene or naphthalimide dye or a fluorophore, chromophore, magnetic particle, gold particle, or isotopic mass label to form a target-associative tag for analyzing, identifying, or purifying phosphorylated proteins |
01/13/2009 | US7476655 Materials and methods for regulating blood flow |
01/13/2009 | US7476654 Administering truncated, homodimeric platlet-derived growth factor-DD optionally with a vascular endothelial growth factor; reduce the leakage of leaky vessels by stimulating the proliferation and migration of smooth muscle cells; wound healing |
01/13/2009 | US7476653 Using growth hormone secretagague receptors; endocrime disorders; gastrointestinal disorders; cardiovascular disorders; central nervous system disorders; antiproliferative agents; antiinflammatory agents |
01/13/2009 | US7476652 by addition of surfactants such as nonionic surfactants of the (poly)ethoxylated fatty acid type; storage stability to hydrophobic aggregation nuclei for several months under temperature stress |
01/13/2009 | US7476651 Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
01/13/2009 | US7476650 Enzyme inhibition |
01/13/2009 | US7476649 Antiproliferative and antiviral proteins and peptides |
01/13/2009 | US7476648 Treating an aneurysm in a form of a protrusion or a knob of size 1-20 mm by applying a crosslinked gelatin hydrogel containing basic fibroblast growth factor to the affected blood vessel site, where the hydrogel gradually releases the growth factor, resulting in occlusion of the lumen |
01/13/2009 | US7476535 Tyrosinase-related gene (TRP2) protein comprising human leukocyte antigen cytotoxic binding recognition points for identifying modulators for diagnosis, prevention and treatment of cancer ; immunotherapy |
01/13/2009 | US7476528 Proteins producing an altered immunogenic response and methods of making and using the same |
01/13/2009 | US7476513 Detecting binding to epitope; use in immunoassays, imaging, diagnosis and treatment of cancer |
01/13/2009 | US7476509 Compounds and methods for modulating functions of nonclassical cadherins |
01/13/2009 | US7476388 Gastrin, and a second dose of an epithelial growth factor; in vivo islet cell regeneration, preexisting diabetes, islet neogenesis |
01/13/2009 | US7476386 Mixed lipopeptide micelles for inducing an immune response |
01/13/2009 | US7476385 Methods of inhibiting IgE responses to thymus-dependent antigens with the anti-gp39 antibody MR1 |
01/13/2009 | US7476384 Death domain containing receptor 4 antibody and methods |
01/13/2009 | US7476381 administration of an effective amount of a CC-chemokine mutant having reduced glycosaminoglycan (GAG)-binding activity as compared to the wild type peptide to a subject with hepatitis; counteracts liver fibrotic injury |
01/13/2009 | CA2400312C Nutritional intervention composition for enhancing and extending satiety |
01/13/2009 | CA2397785C The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy |
01/13/2009 | CA2310659C Method for accelerating protein digestion rate |